<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26982782</article-id>
      <article-id pub-id-type="pmc">4782650</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164081</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dermatopathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical
and dermatopathologic features<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bernardes Filho</surname>
            <given-names>Fred</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Melo</surname>
            <given-names>Alessandro Severo Alves</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pires</surname>
            <given-names>Andr&#xE9;a Rodriguez Cordovil</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lupi</surname>
            <given-names>Omar</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
          <xref ref-type="aff" rid="aff6">6</xref>
          <xref ref-type="aff" rid="aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Neves</surname>
            <given-names>Daniel Gama das</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>da Cruz</surname>
            <given-names>Margareth Fernandes</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kac</surname>
            <given-names>Bernard Kawa</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Instituto de Dermatologia Professor Rubem David Azulay -
Santa Casa de Miseric&#xF3;rdia do Rio de Janeiro (IDPRDA-SCMRJ) - Rio de Janeiro
(RJ), Brazil.</aff>
      <aff id="aff2"><label>2</label>Universidade Federal Fluminense (UFF) - Niter&#xF3;i
(RJ), Brazil.</aff>
      <aff id="aff3"><label>3</label>Hospital Or&#xEA;ncio de Freitas - Niter&#xF3;i (RJ),
Brazil.</aff>
      <aff id="aff4"><label>4</label>Private clinic - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff5"><label>5</label>Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
- Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff6"><label>6</label>Universidade Federal do Rio de Janeiro (UFRJ) - Rio de
Janeiro (RJ), Brazil.</aff>
      <aff id="aff7"><label>7</label>Policl&#xED;nica Geral do Rio de Janeiro (PGRJ) - Rio
de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Fred Bernardes Filho, Rua Marqu&#xEA;s de
Caxias, 9, Sobrado, Centro. 24030-050. - Niter&#xF3;i - RJ
Brazil.<email>f9filho@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>1</issue>
      <fpage>73</fpage>
      <lpage>79</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>12</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>In Brazil, without considering the non-melanoma skin tumors, bladder cancer in
men is the eighth most common, and the urothelial carcinoma or transitional cell
carcinoma is the most common among these. Cutaneous metastases from urothelial
neoplasms appear as single or multiple erythematous, infiltrated nodules or
plaques, and like other cases of distant disease, it is indicative of poor
prognosis. The invasive urothelial carcinoma is recognized for its ability to
present divergent differentiation and morphological variants. The sarcomatoid
urothelial carcinoma is a rare cancer that consists of two different components:
one composed of epithelial tissue and the other with sarcomatoid features of
mesenchymal origin. The authors describe a case of cutaneous metastasis of
sarcomatoid urothelial carcinoma in a 63-year-old male patient.</p>
      </abstract>
      <kwd-group>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Urinary bladder Neoplasms</kwd>
        <kwd>Sarcoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Vesical neoplasms are important in view of the severity of symptoms involved, high
recidivism rates and treatment morbidity.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Bladder tumor is the most common genitourinary tract cancer,
the ninth most common cancer in the world, with over 330,000 new cases/year, more
than 30,000 deaths/year and a 3.8:1 rate between men and women.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup> In Brazil, without taking into account non melanoma skin cancer,
bladder cancer is the eighth most frequent in male patients (6.89/100 thousand men);
in women, it is the 15th most frequent (2.15/100 thousand women).<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>The smoking habit is the most important risk factor for this type of cancer,
responsible for approximately 50-65% of new cases in men and 20-30% of cases in
women.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> The second risk
factor to be emphasized is occupational exposure (polycyclic aromatic hydrocarbons,
formaldehydes and solvents).<sup><xref rid="r6" ref-type="bibr">6</xref></sup>
Chronic aggression to vesical mucosa resulting from long periods of time wearing a
vesical catheter, untreated vesical lithiasis and cystitis caused by
<italic>Schistosoma hematobium</italic> are also associated with the onset of
squamous cell carcinoma in the bladder.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p>
      <p>The most common bladder cancer is the urothelial cell carcinoma, also known as
transitional cell carcinoma. In approximately 30% of patients it is only diagnosed
when there is invasion of the muscle layer.<sup><xref rid="r6" ref-type="bibr">6</xref></sup></p>
    </sec>
    <sec>
      <title>PATHOLOGICAL ANATOMY</title>
      <p>Histologically considered, the wall of the urinary bladder is composed of three
layers: one external tunica adventitia of connective tissue which, in some areas, is
lined by a serous peritoneal membrane, a non striated tunica muscularis (detrusor
bladder muscle) and an internal mucosa membrane that lines the interior of the
bladder (tunica mucosae or urothelium).<sup><xref rid="r7" ref-type="bibr">7</xref></sup></p>
      <p>Normal urothelium is formed by three to seven cellular layers that are on top of the
corion, which contains the muscular layer of the mucosa.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> The deeper cells are called basal and the
superficial ones have a wide and flat umbrella shape. Among them there are one or
more layers of intermediary cells.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>The transitional or urothelial cell carcinoma is different from normal epithelium as
it presents an increased number of cellular layers, with a papillary aspect and loss
of cellular architecture and polarity. They may present a papillary, nodular,
sessile, infiltrative and mixed pattern. They may grow in depth, invading the corion
and the muscular layer characteristic of the bladder.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup></p>
    </sec>
    <sec>
      <title>CUTANEOUS METASTASIS</title>
      <p>The cutaneous metastasis of a visceral primary tumor is uncommon and its incidence
varies between 0.2% and 10.4%; the most common primary tumors that metastasize the
skin depend on the gender of the affected patient and include breast (69%), followed
by colon (9%), lung (4%) and ovary (4%) in women and lung (24%), followed by colon
(19%) and head and neck tumors (12%) in men.<sup><xref rid="r10" ref-type="bibr">10</xref>-<xref rid="r12" ref-type="bibr">12</xref></sup> As regards
malignancy of the genitourinary tract, the incidence of skin involvement is between
1.1% and 2.5% of cases, corresponding to 3.4% of renal cell carcinomas and only
0.84% of urothelial carcinomas. The transitional cell carcinoma usually metastasizes
to lymph nodes, liver, lungs, bones and adrenal glands; cutaneous metastasis is
considered rare.<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r14" ref-type="bibr">14</xref></sup></p>
      <p>Visceral tumors may metastasize to the skin through four mechanisms: (a) direct
invasion from a neoplasm of underlying tissue (contiguity); (b) iatrogenic
implantation on the surgical wound; (c) lymphatic dissemination; (d) hematogenic
dissemination.<sup><xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref></sup></p>
      <p>It should be noted that even superficial urothelial carcinomas show some kind of
dissemination in 20% of the cases; there may be cutaneous metastasization even in
absence of muscle-invasive disease.<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup></p>
      <p>Clinically, cutaneous metastases of urothelial neoplasms appear as plaques or either
single or multiple nodules, erythematous, infiltrated, with an ulcerated or necrotic
aspect. Diagnosis may become difficult as other primary dermatoses, such as
hemangiomas, keratoacanthomas, herpes zoster, erysipelas, boils or even dermatitis
associated with chemotherapy are mimetized. They tipically affect the dermis rather
than the epidermis.<sup><xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r15" ref-type="bibr">15</xref></sup></p>
      <p>Histologically, cutaneous metastases of a visceral carcinoma demonstrate an
uncontrolled infiltrative growth with atypical epithelial cells disposed as single
cells, narrow cords and nests, moving through collagen bundles in the dermis (<xref ref-type="fig" rid="f01">Figure 1</xref>).<sup><xref rid="r16" ref-type="bibr">16</xref></sup> Lymphatic vascular invasion may be present, which favors
the metastatic origin of the tumor. Cutaneous metastases may cytologically resemble
the primary tumor. However, they may be little differentiated and require
immunohistochemical staining to determine their primary origin.<sup><xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref></sup></p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Primary neoplasm invading bladder mucosa and muscles; uncontrolled
infiltrative growth with atypical epithelial cells. 2. Dissected
collagen bundles; 3. Angiogenesis induced by neoplasm; 4.
Undifferentiated atypical epithelioid cells forming cords and irregular
aggregates, without a definite architectural pattern.</p></caption><graphic xlink:href="abd-91-01-0073-g01"/></fig>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male patient, 63 years old, mentioned history of hematuria and intermitent abdominal
pain for seven months. He had undergone multiple treatments for urinary infection
without resolution of clinical symptoms. A genitourinary tract ultrasound scan
revealed a nodular and hyperechogenic image, measuring 37 mm in its larger diameter,
located in the left anterolateral wall of the bladder. As there was suspicion of
vesical tumor, he underwent transurethral bladder resection; complementary
laparotomy and cystectomy were required due to perforation of the organ.</p>
      <p>Histopathological examination of the lesion revealed high grade urothelial carcinoma
(WHO/ISUP) with invasion of the muscle layer and presence of embolus in lymph
vessel. Pathological staging: pT2a, pNx, pMx.</p>
      <p>One month after surgery the patient was hospitalized due to abdominal distension and
pain. During the physical examination he was without fever, eupneic, pulse 88 bpm,
blood pressure 110 x 70 mmHg. At the dermatological examination were observed: an
infraumbilical scar, an erythematous-purpuric plaque, infiltrated, measuring about
10 x 5 cm at the hypogastrium, fistula with urine drainage at midline,
infraumbilical region and two erythematous-wine colored nodules at midline,
suprapubic region (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Erythematous purpuric plaque, infiltrated, located in the infraumbilical
midline scar and two erythematous-wine colored nodules in the midline,
suprapubic region; the black arrow marks the biopsied nodule. Suprapubic
cystostomy with urine leakage</p></caption><graphic xlink:href="abd-91-01-0073-g02"/></fig>
</p>
      <p>Tomography of the abdomen and pelvis with intravenous contrast demonstrated free
liquid; multiple peritoneal nodules of irregular outline and heterogeneous
enhancement, suggesting secondary implants; important thickening of right vesical
wall associated with densification of adjacent fat and mass of heterogeneous
enhancement infiltrating the abdominal wall up to the epidermis in the hypogastrium
region and on the pathway of the surgical incision, where densification of
subcutaneous fat planes and cutaneous nodules can be observed (<xref ref-type="fig" rid="f03">Figure 3</xref>).</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Tomography of abdomen and pelvis: (a) Cut at bladder level, thickening of
right vesical wall associated with densification of adjacent fat and
mass of heterogeneous enhancement infiltrating the abdominal wall up to
the epidermis (white arrows). Contrast excreted by the kidneys in the
interior of the bladder (dotted arrow); (b) Cut below the pubic
symphysis, showing extension of the same mass through the subcutaneous
tissue and the biopsied nodule (white arrow); (c) Cut at kidney level
showing free liquid (*) and peritoneal nodules, of irregular outline and
heterogeneous enhancement, suggestive of secondary implants (white
arrows).</p></caption><graphic xlink:href="abd-91-01-0073-g03"/></fig>
</p>
      <p>A biopsy of one of the nodules located in the midline scar was made and the
histopathological examination revealed a neoplasm composed mainly of atypical
epithelioid and pleomorphic cells, disposed in large compact aggregates, without any
characteristic architecture. Presence of numerous mitoses and areas of necrosis. The
neoplasm occupied the entire dermis (<xref ref-type="fig" rid="f04">Figure
4</xref>). A revision of the histopathology of the bladder lesion demonstrated a
neoplasm predominantly composed of atypical epithelioid and pleomorphic cells,
disposed in large compact aggregates, without any characteristic architecture.
Presence of numerous mitoses and areas of necrosis. A neoplasm reached the muscular
layer (<xref ref-type="fig" rid="f05">Figure 5</xref>).</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Skin - Histopathologic findings: neoplasm composed predominantly of atypical
and pleomorphic epithelioid cells, disposed in large compact aggregates,
without any characteristic architecture. Presence of numerous mitoses and
areas of necrosis. The neoplasm occupies all the dermis (hematoxilin and
eosin staining; (A) 4x; (B) 10x; (C) 40x)</p>
        </caption>
        <graphic xlink:href="abd-91-01-0073-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>Bladder - Histopathologic findings: neoplasm composed predominantly of
atypical and pleomorphic epithelioid cells, disposed in large compact
aggregates, without any characteristic architecture. Presence of numerous
mitoses and areas of necrosis. The neoplasm reaches the muscular wall
[hematoxilin and eosin staining; (A) 4x; (B) 10x; (C) 40x)].</p>
        </caption>
        <graphic xlink:href="abd-91-01-0073-g05"/>
      </fig>
      <p>An immunohistochemical examination of the bladder lesion demonstrated neoplastic
cells with the following immunomarking profile: immunopositivity with the
antivimentin (diffuse) and cytokeratin antibodies AE1/AE3 (rare cells);
immunonegativity with the anti CD34 antibody (<xref ref-type="fig" rid="f06">Figure
6</xref>).</p>
      <fig id="f06" orientation="portrait" position="float">
        <label>Figure 6</label>
        <caption>
          <p>Bladder - immunomarking profile: immunopositivity with anti vimentin
(diffuse) (A, 4x; B, 40x) and cytokeratin AE1/AE3 (rare cells) (C, 4x; D,
40x) antibodies</p>
        </caption>
        <graphic xlink:href="abd-91-01-0073-g06"/>
      </fig>
      <fig id="f07" orientation="portrait" position="float">
        <label>Figure 7</label>
        <caption>
          <p>Skin - immunomarking profile: immunopositivity with anti vimentin (diffuse)
(A, 4x; B, 40x)</p>
        </caption>
        <graphic xlink:href="abd-91-01-0073-g07"/>
      </fig>
      <p>An immunohistochemical examination of the cutaneous nodule showed neoplastic cells
with the following immunomarking profile: immunopositivity with the antivimentin
antibody (diffuse); imunonegativity with all other tested antibodies:
cytokeratin-cocktail, clone AE1/AE3, CK5, CK7, CK20, melan-A, <italic>Renal Cell
Carcinoma Marker</italic> (RCC); CD34, CD45 (LCA), protein p63, prostatic
specific antigen (PSA), smooth muscle actin, protein S-100 and epithelial membrane
antigen (EMA) (<xref ref-type="fig" rid="f07">Figure 7</xref>).</p>
      <p>The patient was referred to oncology for treatment, but passed away thirty days after
the diagnosis of cutaneous invasion.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>It is undeniable that cancer is a public health problem, whose prevention and early
diagnosis should be prioritized. The diagnosis of a tumor in advanced stage implies
in systemic treatment, that is, use of chemotherapy, hormone therapy or
target-therapies. In these cases, local treatments, such as radiotherapy or surgery,
will usually have no curative effect.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> The invasive
urothelial carcinoma is recognized for its capacity of divergent differentiation and
presentation of morphological variants. WHO acknowledges as main variants of the
urothelial carcinoma: squamous, glandular differentiation, nests, microcystic,
micropapilliferous, lymphoepithelioma-simile, lymphoma-simile and plasmocytoid,
sarcomatoid (with and without heterologous elements), trophoblastic differentiation,
clear cells and lipidic cells.<sup><xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup></p>
      <p>The recognition of morphological variants is of great importance in the differential
diagnosis with non neoplastic lesions and other malignant neoplasms, including
secondary vesical involvement by another carcinoma or sarcoma. The presence of a
morphological variant is associated with a more aggressive biological behavior of
urothelial carcinomas and may even reflect in the option for therapeutic conducts
different from the customarily used in the conventional urothelial
carcinoma.<sup><xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup></p>
      <p>The sarcomatoid bladder carcinoma is a rare neoplasm composed of two different
components. One is formed by epithelial tissue with malignant characteristics
(carcinoma) and another has sarcomatoid characteristics, of mesenchymal origin. Some
authors suggest the use of the term sarcomatoid carcinoma for cases without
heterologous mesenchymal elements in the composition of fusiform cells.
Macroscopically, they present as exophytic polypoid masses, voluminous (5.7cm on
average) and with necrosis and ulceration areas.<sup><xref rid="r20" ref-type="bibr">20</xref></sup></p>
      <p>Histogenesis is controversial. Some authors suggest that these tumors develop as a
result of the ability of undifferentiated, totipotentiary neoplastic cells to be the
origin of multiple pathways of terminal differentiation in histologically recognized
mesenchymal and epithelial elements. As basis for this theory stand out the
existence of immunoreactivity for epithelial markers (cytokeratin and epithelial
membrane antigen - EMA) in mesenchymal areas, as well as the presence of
ultrastructural epithelial differentiation parameters (desmosomes and tonofilaments)
in sarcomatoid elements. Other authors defend the theory that there is a tumoral
"collision", saying that there are two independent malignant tumors, mutually
invasive. A third theory points to the possibility of occurrence of metaplasia of
malignant epithelial elements to sarcomatoid elements, based on the presence of
staining for keratins (AE1/AE3) both in the epithelial component and in the
mesenchymal component.<sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup></p>
      <p>The most frequently found epithelial component is the high grade transitional
carcinoma (80%), followed by squamous cell carcinoma (32%), adenocarcinoma (26%) and
small cell carcinoma (5%). In about 33% of cases, two or more epithelial components
may coexist. As for the mesenchymal components, the most frequent is the
osteosarcoma (37%), followed by the condrosarcoma (20-47%), the rabdomyosarcoma
(20%), the undifferentiated sarcoma of fusiform cells (l7%) and leiomyosarcoma
(7%).<sup><xref rid="r20" ref-type="bibr">20</xref></sup></p>
      <p>As the transitional cell carcinomas, the sarcomatoid bladder carcinomas may present
with hematuria, dysuria and urinary infection. The histological diagnosis is done
based on the hematoxilin-eosin test and immunohistochemical study (cytokeratins in
the epithelial component and vimentin, desmin HHF-35, SMA or S100 in the mesenchymal
component).<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup></p>
      <p>The differential diagnosis should be done with primary sarcomas, primary carcinomas
with stromal metaplasia, carcinomas with pseudosarcomatous stroma, sarcomas
associated with pseudoepitheliomatous hyperplasia, teratomas and prostate carcinomas
with extension to the bladder. As a consequence of the rarity of bladder sarcomas in
adults, the hypothesis of sarcomatoid carcinoma should be considered in the presence
of a malignant tumor of fusiform cells until there is immunohistochemical
confirmation.<sup><xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref></sup></p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>The cutaneous dissemination of urothelial neoplasms, as in other cases of disease in
distant sites, is indicative of poor prognosis. It occurs mostly in late phases of
the tumor and are the first sign of dissemination only in punctual cases. Its
identification may be made difficult due to its presentation identical to primary
skin diseases, but should be part of the differential diagnosis in oncologic
patients.</p>
      <p>In this case, as a result of the extension of the tumor and presence of metastatic
nodules in the scar of the surgical wound, the propagation of the carcinoma will
probably have a mixed mechanism: contiguity and iatrogenic implantation in the
surgical wound. The sarcomatoid bladder carcinomas, although rare and of difficult
diagnosis, deserve special attention in consequence of their aggressive
behavior.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Study carried out at the laboratory Fonte Medicina Diagn&#xF3;stica - Niteroi (RJ),
Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Lucon</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Falci</surname>
              <given-names>R.</given-names>
              <suffix>Junior</suffix>
            </name>
          </person-group>
          <chapter-title>C&#xE2;ncer de bexiga</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Lopes</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <source>Tratado de Cl&#xED;nica M&#xE9;dica</source>
          <volume>II</volume>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Roca</publisher-name>
          <year>2006</year>
          <fpage>2923</fpage>
          <lpage>2930</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Babjuk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zigeuner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shariat</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>van Rhijn</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Comp&#xE9;rat</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EAU guidelines on non-muscle-invasive urothelial carcinoma of the
bladder: update 2013</article-title>
          <source>Eur Urol</source>
          <year>2013</year>
          <volume>64</volume>
          <fpage>639</fpage>
          <lpage>653</lpage>
          <pub-id pub-id-type="pmid">23827737</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ploeg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Aben</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Kiemeney</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>The present and future burden of urinary bladder cancer in the
world</article-title>
          <source>World J Urol</source>
          <year>2009</year>
          <year>27</year>
          <fpage>289</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">19219610</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="book">
          <comment><ext-link ext-link-type="uri" xlink:href="http://Inca.gov.br">Inca.gov.br</ext-link> [internet]</comment>
          <person-group person-group-type="author">
            <collab>Instituto Nacional de C&#xE2;ncer Jos&#xE9; Alencar Gomes da
Silva</collab>
            <collab>Coordena&#xE7;&#xE3;o de Preven&#xE7;&#xE3;o e
Vigil&#xE2;ncia</collab>
          </person-group>
          <source>Estimativa 2014: Incid&#xEA;ncia de C&#xE2;ncer no Brasil</source>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>INCA</publisher-name>
          <year>2014</year>
          <size units="pages">124</size>
          <date-in-citation content-type="access-date">27 maio 2014</date-in-citation>
          <comment>Dispon&#xED;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.inca.gov.br/estimativa/2014/estimativa-24042014.pdf">http://www.inca.gov.br/estimativa/2014/estimativa-24042014.pdf</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freedman</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Silverman DT Hollenbeck</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Schatzkin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abnet</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Association between smoking and risk of bladder cancer among men
and women</article-title>
          <source>JAMA</source>
          <year>2011</year>
          <volume>306</volume>
          <fpage>737</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="pmid">21846855</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witjes</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Comp&#xE9;rat</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cowan</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>De Santis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gakis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lebret</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EAU guidelines on muscle-invasive and metastatic bladder cancer:
summary of the 2013 guidelines</article-title>
          <source>Eur Urol</source>
          <year>2014</year>
          <volume>65</volume>
          <fpage>778</fpage>
          <lpage>792</lpage>
          <pub-id pub-id-type="pmid">24373477</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Warwick</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dyson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bannister</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <source>Gray Anatomia</source>
          <edition>37th ed</edition>
          <publisher-loc>London</publisher-loc>
          <publisher-name>Guanabara Koogan</publisher-name>
          <year>1995</year>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engel P Anagnostaki</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Braendstrup</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>The muscularis mucosae of the human urinary bladder. implications
for tumor staging on biopsies</article-title>
          <source>Scand J Urol Nephrol</source>
          <year>1992</year>
          <volume>26</volume>
          <fpage>249</fpage>
          <lpage>252</lpage>
          <pub-id pub-id-type="pmid">1439600</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amin</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Histological variants of urothelial carcinoma: diagnostic,
therapeutic and prognostic implications</article-title>
          <source>Mod Pathol</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>S96</fpage>
          <lpage>S118</lpage>
          <pub-id pub-id-type="pmid">19494856</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alcaraz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>R&#xFC;tten</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kutzner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Requena</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastases from internal malignancies: a
clinicopathologic and immunohistochemical review</article-title>
          <source>Am J Dermatopathol</source>
          <year>2012</year>
          <volume>34</volume>
          <fpage>347</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">22617133</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussein</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Skin metastasis: a pathologist's perspective</article-title>
          <source>J Cutan Pathol</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>e1</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">19922483</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kalb</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Helm</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Zeitouni</surname>
              <given-names>NC</given-names>
            </name>
          </person-group>
          <article-title>The Presentation, Pathology, and Current Management Strategies of
Cutaneous Metastasis</article-title>
          <source>N Am J Med Sci</source>
          <year>2013</year>
          <volume>5</volume>
          <fpage>499</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">24251266</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mueller</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hudes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Topham</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lessin</surname>
              <given-names>SR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cutaneous metastases from genitourinary
malignancies</article-title>
          <source>Urology</source>
          <year>2004</year>
          <volume>63</volume>
          <fpage>1021</fpage>
          <lpage>1026</lpage>
          <pub-id pub-id-type="pmid">15183939</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Block</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Dahmoush</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Konety</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metastases from transitional cell carcinoma of the
bladder</article-title>
          <source>Urology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>846.e15</fpage>
          <lpage>846.e17</lpage>
          <page-range>846.e15-7</page-range>
          <pub-id pub-id-type="pmid">16600346</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akman Y Cam</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kavak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alper</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Extensive cutaneous metastasis of transitional cell carcinoma of
the bladder</article-title>
          <source>Int J Urol</source>
          <year>2003</year>
          <volume>10</volume>
          <fpage>103</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">12588608</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swick</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Superficially invasive transitional cell carcinoma of the bladder
associated with distant cutaneous metastases</article-title>
          <source>J Cutan Pathol</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>1245</fpage>
          <lpage>1250</lpage>
          <pub-id pub-id-type="pmid">19919656</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ulbright</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Younger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bostwick</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>MO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytokeratin 7 and cytokeratin 20 in primary urinary bladder
carcinoma and matched lymph node metastasis</article-title>
          <source>Arch Pathol Lab Med.</source>
          <year>2001</year>
          <volume>125</volume>
          <fpage>921</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">11419977</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Mattedi</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <source>Carcinomas uroteliais de bexiga: aspectos anatomopatol&#xF3;gicos e
imuno-histoqu&#xED;micos. Pesquisa de metaloproteinases de matriz
utilizando a t&#xE9;cnica de tissue microarray (TMA)</source>
          <comment>[tese]</comment>
          <publisher-loc>S&#xE3;o Paulo (SP)</publisher-loc>
          <publisher-name>Universidade de S&#xE3;o Paulo</publisher-name>
          <year>2011</year>
          <size units="pages">184</size>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venyo</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Titi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Sarcomatoid variant of urothelial carcinoma (carcinosarcoma,
spindle cell carcinoma): a review of the literature</article-title>
          <source>ISRN Urol</source>
          <year>2014</year>
          <volume>2014</volume>
          <fpage>794563</fpage>
          <lpage>794563</lpage>
          <pub-id pub-id-type="pmid">24587922</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma Sarcomat&#xF3;ide da Bexiga</article-title>
          <source>Acta Urol&#xF3;gica</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>61</fpage>
          <lpage>64</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
